Documents Actelion-InitiationBarclay 2010

EQUITY RESEARCH Healthcare | European Pharmaceuticals | 23 July 2010 ACTELION To be or not to be a biotech company Initiating with a 1-Overweight rating – generic risk…

Health & Medicine Crohns symposium mathew philps beyond biologicals

1. Drugs beyond Biologicals Mathew Philip PVS Memorial Hospital Kochi 2. Drugs beyond current Biologicals Mathew Philip PVS Memorial Hospital Kochi 3. Mucosal Healing 4.…

Documents Can dose-optimization trials be conducted ethically in low-income countries? Dr Andrew Hill World...

Slide 1 Can dose-optimization trials be conducted ethically in low-income countries? Dr Andrew Hill World AIDS Conference, Melbourne, Australia July 2014 [TUWS1104] Slide…

Documents Management of Biologic Therapies in IBD Stephen B. Hanauer, MD Clifford Joseph Barborka Professor of...

PowerPoint Presentation Management of Biologic Therapies in IBD Stephen B. Hanauer, MD Clifford Joseph Barborka Professor of Medicine Northwestern University Feinberg School…